Bone drug helped stave off breast cancer
CHICAGO (Reuters) - A drug used to strengthen the bones of women with breast cancer helped cut the risk of the cancer returning by 36 percent, European researchers said on Saturday,
<p><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=k7mnwt" border="0"></img> (http://feeds.feedburner.com/~a/reuters/healthNews?a=k7mnwt)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=BGv8gH" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=BGv8gH) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=QyUpKh" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=QyUpKh) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=p1pzwh" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=p1pzwh)
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/301873696" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/healthNews/~3/301873696/idUSN3141912620080531